Investigation of EGFR mutations in non-small cell lung cancer usually undetectable by PCR methods

Epidermal growth factor receptor (EGFR) mutations are the most significant genomic drivers of non-small cell lung cancer (NSCLC) and determine the efficacy of EGFR tyrosine kinase inhibitor (EGFR-TKI) therapy. PCR methods are used clinically for the detection of EGFR mutations. The Scorpion Amplific...

Descripción completa

Detalles Bibliográficos
Autores principales: Matsubara, Taisuke, Nakajima, Eiji, Namikawa, Haruka, Ono, Shotaro, Takada, Ikki, Ohira, Tatsuo, Morishita, Yukio, Miyazaki, Teruo, Furukawa, Kinya, Ikeda, Norihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637854/
https://www.ncbi.nlm.nih.gov/pubmed/34881035
http://dx.doi.org/10.3892/mco.2021.2447

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8637854/
https://www.ncbi.nlm.nih.gov/pubmed/34881035
http://dx.doi.org/10.3892/mco.2021.2447

Ejemplares similares